Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
TIMM23B - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
PCNP - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
SFR1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
JKAMP - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
WDR11 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MTMR12 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
YME1L1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LAPTM4B - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GFM1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SRSF11 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ESD - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TTC37 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
WDR89 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SFPQ - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SEC23B - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SUB1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TXNDC9 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RCBTB1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SRP9 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RNF11 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on